Tetraphase Pharmaceuticals
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Tetraphase Pharmaceuticals sits in the top decile of US sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count).
Tetraphase Pharmaceuticals: 13 sponsored US clinical trials, 1 recruiting.
Tetraphase Pharmaceuticals sponsors 13 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 12 completed. 4 of these trials are in Phase 3-4 (later-stage) and 9 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Complicated Intra-abdominal Infections, with 1 trials.
Top-decile sponsor footprint
Tetraphase Pharmaceuticals ranks in the top decile of sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
12 of 12 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
13 total, page 1 of 1
A Study to Evaluate the Safety and Tolerability of Eravacycline in Pediatric Patients Aged 8 to 17 With Complicated Intra-abdominal Infections (cIAI)
NCT06794541
A Safety and PK Study of IV Eravacycline
NCT03696550
A Phase 1 TP-271 Oral PK Multiple Ascending Dose Study
NCT03450187
A Phase 1 Safety and PK Study of IV TP-271
NCT03234738
A Phase 1 TP-271 Oral PK Single Ascending Dose Study
NCT03024034
Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Participants With Complicated Urinary Tract Infections
NCT03032510
Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections
NCT02784704
A Phase 1 Study to Assess the Safety, Tolerability and PK of IV TP-271
NCT02724085
Efficacy and Safety Study of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract Infections
NCT01978938
A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With Impaired Hepatic Function and Healthy Subjects
NCT02135302
Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal Infections
NCT01844856
Safety and Pharmacokinetic (PK) Study to Assess Bronchopulmonary Disposition of IV Eravacycline (TP-434) in Healthy Men and Women
NCT01989949
Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections
NCT01265784
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 7 |
| Phase 2 | 2 |
| Phase 3 | 4 |
What is open in the Tetraphase Pharmaceuticals pipeline
1 recruiting of 13 indexed (8% open); 12 completed (92%).
Phase mix: 4 late (III/IV) vs 9 early (I/II) (early-phase heavy).
Top condition: Complicated Intra-abdominal Infections (1 trial), 4 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Tetraphase Pharmaceuticals: open-pipeline peers nationwide
Peers matched on 13 registered trials and 8% open enrollment, not the therapeutic-area sidebar.
Tetraphase Pharmaceuticals sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 13 trials (± recruiting share)
- Adaptimmune · 13 trials · 0% recruiting
- Agennix · 13 trials · 0% recruiting
- Akili Interactive Labs · 13 trials · 0% recruiting
- Alumis · 13 trials · 8% recruiting
Sponsors near 8% open enrollment (± trial volume)
- Andrei Iagaru · 8% recruiting · 13 trials
- BioXcel Therapeutics · 8% recruiting · 13 trials
- Corporal Michael J. Crescenz VA Medical Center · 8% recruiting · 13 trials
- Fresenius Medical Care North America · 8% recruiting · 13 trials
Related
What to do with this Tetraphase Pharmaceuticals page
13 registered trials is a research-attention snapshot, not an endorsement of Tetraphase Pharmaceuticals or any single study.
- 1 of Tetraphase Pharmaceuticals's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Complicated Intra-abdominal Infections is the condition Tetraphase Pharmaceuticals studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Complicated Intra-abdominal Infections trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Tetraphase Pharmaceuticals pipeline card: 13 registered trials from official public datasets.Report a data error.